Since OpenPrescribing Hospitals launched, you've asked: what about biosimilars? Primary care can track them; secondary care still cannot. Find out why 👇
You asked: Can we monitor the usage of biosimilars in secondary care using OpenPrescribing Hospitals? | Bennett Institute for Applied Data Science
What are biosimilars, why are they of interest and why can we monitor usage with primary care data but not secondary care data?
bennett.ox.ac.uk